FOLH1 and prostate carcinoma: Prostate-specific membrane antigen (PSMA) is a type II membrane glycoprotein that exhibits high expression in both dedifferentiated and castration-resistant prostate cancer [7, 8], rendering radiolabelled PSMA imaging invaluable for detecting metastatic prostates cancer [9].